Medicare Enrolled
Dr. Jill Ruiz, MD
Student in an Organized Health Care Education/Training Program · Denison, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ruiz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ruiz? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ruiz
Dr. Jill Ruiz is a student in an organized health care education/training program in Denison, TX, with 18 years in practice. Based on federal Medicare data, Dr. Ruiz performed 85,663 Medicare services across 3,387 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ruiz received a total of $392 from 13 pharmaceutical and/or device companies across 21 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ruiz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 0% volume in TX$ $392 industry payments
Medicare Practice Summary
Medicare Utilization ↗85,663
Medicare services
Top 0% in TX for student in an organized health care education/training program
3,387
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,759 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 23,970 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 13,000 | $43 | $136 |
| Iron sucrose injection (Venofer) | 8,400 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 8,075 | $2 | $20 |
| Paclitaxel chemotherapy injection | 6,802 | $0 | $8 |
| Oxaliplatin chemotherapy injection | 6,000 | $0 | $33 |
| Contrast dye for imaging (iodine-based) | 4,535 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 2,220 | $18 | $66 |
| CT guidance for radiation therapy | 1,723 | $92 | $611 |
| Dexamethasone injection (steroid) | 1,500 | $0 | $1 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 1,247 | $269 | $2,762 |
| Injection, granisetron hydrochloride, 100 mcg | 620 | $0 | $24 |
| Continuing radiation therapy consultation per week | 509 | $65 | $343 |
| Radiation treatment management, 5 treatment sessions | 487 | $146 | $1,067 |
| Calculation of radiation therapy dose | 405 | $50 | $365 |
| Injection, leucovorin calcium, per 50 mg | 358 | $3 | $25 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 339 | $177 | $700 |
| Injection, fluorouracil, 500 mg | 293 | $2 | $13 |
| Administration of chemotherapy into vein, 1 hour or less | 272 | $97 | $707 |
| Design and construction of complex radiation treatment device | 243 | $93 | $710 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 241 | $177 | $700 |
| Anti-nausea injection (Aloxi/palonosetron) | 230 | $1 | $114 |
| Injection, cisplatin, powder or solution, 10 mg | 217 | $2 | $94 |
| Injection, carboplatin, 50 mg | 215 | $2 | $300 |
| Injection of additional new drug or substance into vein | 207 | $11 | $108 |
| Office visit, established patient (30-39 min) | 168 | $90 | $368 |
| Complex radiation therapy planning | 159 | $127 | $1,022 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 154 | $515 | $1,355 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 152 | $3 | $373 |
| Injection, zoledronic acid, 1 mg | 144 | $6 | $431 |
| New patient office visit, complex (60-74 min) | 141 | $163 | $709 |
| Cranial lesion surgery using radiation over multiple sessions | 139 | $754 | $8,210 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 136 | $22 | $157 |
| PSA test (prostate cancer screening) | 130 | $18 | $94 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 130 | $46 | $313 |
| Blood draw (venipuncture) | 122 | $8 | $20 |
| Injection, magnesium sulfate, per 500 mg | 100 | $1 | $6 |
| High precision radiation therapy planning | 99 | $1,367 | $6,431 |
| Design and construction of radiation treatment device for high precision radiation therapy | 99 | $346 | $2,640 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 98 | $1,102 | $4,802 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 93 | $55 | $211 |
| X-ray during radiation therapy | 92 | $10 | $126 |
| Drug injection, under skin or into muscle | 90 | $11 | $96 |
| Irrigation of implanted venous access drug delivery device | 88 | $17 | $114 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 88 | $90 | $657 |
| Administration of chemotherapy into vein, each additional hour | 82 | $21 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 73 | $49 | $344 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 67 | $202 | $704 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 67 | $342 | $1,341 |
| Injection, diphenhydramine hcl, up to 50 mg | 65 | $1 | $7 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 65 | $325 | $1,722 |
| Infusion, normal saline solution , 1000 cc | 57 | $2 | $19 |
| Ct scan of chest with contrast | 50 | $55 | $821 |
| Unclassified drugs | 45 | $1 | $8 |
| High dose radiation therapy, 2-12 channels | 42 | $457 | $2,416 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 41 | $138 | $3,675 |
| Complete blood count (CBC) with differential | 39 | $8 | $36 |
| CT scan of abdomen and pelvis with contrast | 38 | $162 | $1,067 |
| 3d radiation therapy planning | 37 | $365 | $4,374 |
| Design and construction of simple radiation treatment device | 34 | $29 | $296 |
| Comprehensive metabolic blood panel | 33 | $10 | $64 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 33 | $124 | $500 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 32 | $26 | $145 |
| Administration of additional new drug or substance into vein using push technique | 32 | $42 | $289 |
| Obtaining respiratory data needed to develop the optimal radiation treatment | 31 | $314 | $1,838 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 31 | $15 | $94 |
| Management of cranial lesion surgery using radiation over multiple sessions | 28 | $492 | $3,609 |
| Blood creatinine level | 27 | $5 | $31 |
| Manual urinalysis test with examination using microscope, non-automated | 22 | $4 | $26 |
| Infusion into a vein for hydration, each additional hour | 20 | $10 | $75 |
| Drawing of blood for a medical problem | 15 | $63 | $264 |
| New patient office visit (45-59 min) | 15 | $124 | $565 |
| Office visit, established patient, complex (40-54 min) | 12 | $125 | $496 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.7% high complexity
68.4% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$392
Total received (2018-2024)
Avg $65/year across 6 years
Top 38% in TX for student in an organized health care education/training program
13
Companies
21
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$392 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$66
2023$71
2022$65
2020$35
2019$67
2018$89
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$52
Novartis Pharmaceuticals Corporation
$51
Amgen Inc.
$49
Dova Pharmaceuticals
$35
Medtronic, Inc.
$32
Lilly USA, LLC
$27
Medtronic USA, Inc.
$26
Incyte Corporation
$26
Merck Sharp & Dohme LLC
$24
Celgene Corporation
$24
GENZYME CORPORATION
$19
Stemline Therapeutics Inc.
$15
TerSera Therapeutics LLC
$13
Top 3 companies account for 38.9% of total payments
Associated products mentioned in payments ›
Abraxane · CABLIVI · Doptelet · ERBITUX · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · MEKINIST · MVASI · Neulasta · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · Orserdu · TAGRISSO · VERZENIO · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $0 per 100 Medicare services performed
Geographic Context
Student in an Organized Health Care Education/Training Programs within 10 mi
52
Per 100K population
37.1
County median income
$70,455
Nearest hospital
TEXOMA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ruiz is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ruiz experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ruiz performed 23,970 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ruiz receive payments from pharmaceutical companies?
Yes. Dr. Ruiz received a total of $392 from 13 companies across 21 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ruiz's costs compare to other student in an organized health care education/training programs in Denison?
Dr. Ruiz's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ruiz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student in an Organized Health Care Education/Training Programs in Denison
Browse student in an organized health care education/training programs in Denison ranked by procedure volume and transparency data.
Highest volume
Top Student in an Organized Health Care Education/Training Programs in TX
Student in an Organized Health Care Education/Training Programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student in an Organized Health Care Education/Training Programs in TX
Which TX student in an organized health care education/training programs receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology